mRNAT,

Chenshuang Zhang1, William Stewart2, Yilong Teng1

  • 1National Key Laboratory of Innovative Immunotherapy, Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China.

ACS nano
|October 28, 2025
PubMed
概括

这项研究介绍了VISIT,一种新型的疫苗策略,该策略在体内重新编程树突细胞,以增强癌症免疫疗法. VISIT有效地增强了抗原特异性T细胞反应,导致瘤排斥和长期免疫力.